News

The company's Corporate Governance Evaluation result for the 103rd fiscal year was ranked in the top 20% of TPEx-listed comp

The Company will participate in the investor forum held by Grand Cathay Securities on March 28, 2014.

Company Receives U.S. Approval for Skin Aging and Inflammation Therapy

Company Secures New Zealand Approval for Two Drug Patents: Viral Warts and Skin Aging/Inflammation Therapy

Economic Daily News - D&E Biotech's Hepanamin Obtains Drug Approval